These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 15035889

  • 1. Integrative tumor board: recurrent breast cancer or new primary? Case Presentation.
    Schmaltz J.
    Integr Cancer Ther; 2003 Sep; 2(3):268-70. PubMed ID: 15035889
    [No Abstract] [Full Text] [Related]

  • 2. Integrative tumor board: recurrent breast cancer or new primary? Medical oncology.
    Boyd DB.
    Integr Cancer Ther; 2003 Sep; 2(3):270-2. PubMed ID: 15035890
    [No Abstract] [Full Text] [Related]

  • 3. Integrative tumor board: recurrent breast cancer or new primary? Radiation oncology.
    Hirsch A.
    Integr Cancer Ther; 2003 Sep; 2(3):272-6. PubMed ID: 15035891
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Integrative tumor board: recurrent breast cancer or new primary? UCSF Osher Center for Integrative Medicine and UCSF Carol Franc Buck Breast Care Center.
    Jacobs BP, Burns B, Marya R, Chapman J, Stone B, Hwang S, Goldman M, Barrows K, Hamolsky D, Sampel K.
    Integr Cancer Ther; 2003 Sep; 2(3):289-300. PubMed ID: 15035894
    [No Abstract] [Full Text] [Related]

  • 6. Integrative tumor board: recurrent breast cancer or new primary? Mind-body-spirit medicine.
    Mehl-Madrona L.
    Integr Cancer Ther; 2003 Sep; 2(3):283-9. PubMed ID: 15035893
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Follow-up care of patients with breast cancer.
    Tolaney SM, Winer EP.
    Breast; 2007 Dec; 16 Suppl 2():S45-50. PubMed ID: 17697780
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Possibilities of the cytological method in the determination of therapeutic pathomorphosis of breast cancer].
    Sidorova NA, Volchenko NN, Saribekian EK.
    Sov Med; 1991 Dec; (11):15-8. PubMed ID: 1662831
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mucoepidermoid carcinoma of the breast.
    Hornychová H, Ryska A, Betlach J, Bohác R, Cízek T, Tomsová M, Obermannová R.
    Neoplasma; 2007 Dec; 54(2):168-72. PubMed ID: 17319792
    [Abstract] [Full Text] [Related]

  • 15. Some clarity in the management of DCIS in breast cancer screening.
    Wald NJ.
    J Med Screen; 2011 Dec; 18(3):112. PubMed ID: 22045817
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The immediate results of the combined treatment of stage-III breast cancer].
    Muratkhodzhaev NK, Letiagin VP, Khodzhaev AV.
    Vopr Onkol; 1990 Dec; 36(10):1227-31. PubMed ID: 2174591
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Current management of primary breast cancer. Part II: Adjuvant therapy and management of stage III disease and in-situ carcinoma.
    Lopez MJ, Andriole DP.
    Mo Med; 1990 Oct; 87(10):757-62. PubMed ID: 2175383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.